Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Status:
Recruiting
Trial end date:
2028-05-26
Target enrollment:
Participant gender:
Summary
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known
medicine, which is already used by doctors to treat type 2 diabetes in many countries.
Participants will either get semaglutide or a dummy medicine - which treatment participants
get is decided by chance.
Participants will need to inject themselves with medicine under the skin. Participants will
need to do this once a week.
The study will last for about 5 years. Participants will have up to 21 clinic visits and up
to 9 phone calls with the clinical staff during the study. Some of the clinic visits may be
spread over more than one day.
Women cannot take part in the study if they are pregnant, breast-feeding or plan to become
pregnant during the study period.